N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration

Schizophrenia Research

Volumn 73, Issue 2-3, 2005, Pages 209-219

  Molina, Vicente ^a   Sánchez, Javier ^b   Reig, Santiago ^b   Sanz, Javier ^c   Benito, Carlos ^b   Santamarta, Cristina ^b   Pascau, Javier ^b   Sarramea, Fernando ^d   Gispert, Juan D ^b   Misiego, José M ^c   Palomo, Tomás ^c   Desco, Manuel ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Disease duration; MRS; N acetyl aspartate; Neurodegeneration; Prefrontal lobe; Schizophrenia

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LEFT HEMISPHERE; MALE; ONSET AGE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; ASPARTIC ACID; CHOLINE; CHRONIC DISEASE; CREATINE; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; RISPERIDONE; SCHIZOPHRENIA; TIME FACTORS;

EID: 19944428011     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.02.001     Document Type: Article

References (52)

1. Angelie E., Bonmartin A., Boudraa A., Gonnaud P.M., Mallet J.J., Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. Am. J. Neuroradiol. 22:2001;119-127
2. Bartha R., al-Semaan Y.M., Williamson P.C., Drost D.J., Malla A.K., Carr T.J., Densmore M., Canaran G., Neufeld R.W. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol. Psychiatry. 45:1999;1403-1411
3. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 153:1996;1554-1563
4. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry. 43:1998;641-648
5. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz R.M., Jacobsen L., Barnett I.S., Duyn J.H., Frank J.A., Rapoport J.L., Weinberger D.R. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 155:1998;1376-1383
6. Bertolino A., Callicott J.H., Mattay V.S., Weidenhammer K.M., Rakow R., Egan M.F., Weinberger D.R. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol. Psychiatry. 49:2001;39-46
7. Bertolino A., Sciota D., Brudaglio F., Altamura M., Blasi G., Bellomo A., Antonucci N., Callicott J.H., Goldberg T.E., Scarabino T., Weinberger D.R., Nardini M. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am. J. Psychiatry. 160:2003;483-489
8. Block W., Bayer T.A., Tepest R., Traber F., Rietschel M., Muller D.J., Schulze T.G., Honer W.G., Maier W., Schild H.H., Falkai P. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci. Lett. 289:2000;147-151
9. Boogaart A., Ormondt D., Pijnapel W.W.F., Beer R.D., Ala-Korpela M. Removal of the water resonance from 1H magnetic resonance spectra. McWhiter J.G. Mathematics in Processing III. 1994;175-195 Clarendon Press, Oxford
10. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 508:1987;333-348
11. Brooks J.C., Roberts N., Kemp G.J., Gosney M.A., Lye M., Whitehouse G.H. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb. Cortex. 11:2001;598-605
12. Buckley P.F., Moore C., Long H., Larkin C., Thompson P., Mulvany F., Redmond O., Stack J.P., Ennis J.T., Waddington J.L. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry. 36:1994;792-800
13. Bustillo J.R., Lauriello J., Rowland L.M., Jung R.E., Petropoulos H., Hart B.L., Blanchard J., Keith S.J., Brooks W.M. Effects of Chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Res. 107:2001;135-149
14. Callicott J.H., Bertolino A., Egan M.F., Mattay V.S., Langheim F.J., Weinberger D.R. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am. J. Psychiatry. 157:2000;1646-1651
15. Cecil K.M., Lenkinski R.E., Gur R.E., Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 20:1999;131-140
16. Deicken R.F., Zhou L., Corwin F., Vinogradov S., Weiner M.W. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am. J. Psychiatry. 154:1997;688-690
17. Deicken R.F., Zhou L., Schuff N., Weiner M.W. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr. Res. 27:1997;65-71
18. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol. Psychiatry. 43:1998;483-488
19. Deicken R.F., Johnson C., Eliaz Y., Schuff N. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am. J. Psychiatry. 157:2000;644-647
20. Delamillieure P., Fernandez J., Constans J.M., Brazo P., Benali K., Abadie P., Vasse T., Thibaut F., Courtheoux P., Petit M., Dollfus S. Proton magnetic resonance spectroscopy of the medical prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry. 157:2000;641-643
21. Delamillieure P., Constans J.M., Fernandez J., Brazo P., Benali K., Courtheoux P., Thibaut F., Petit M., Dollfus S. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr. Bull. 28:2002;329-339
22. DeLisi L.E. Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Res. 92:1999;1-9
23. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., Henn F.A. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr. Res. 41:2000;389-395
24. Ende G., Braus D.F., Walter S., Henn F.A. Lower concentration of thalamic N-acetylaspartate in patients with schizophrenia: a replication study. Am. J. Psychiatry. 158:2001;1314-1316
25. Ende G., Braus D.F., Walter S., Weber-Fahr W., Henn F.A. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 253:2003;9-15
26. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., Shew C., Sharma T. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol. Psychiatry. 54:2003;587-598
27. Fukuzako H., Fukuzako T., Hashiguchi T., Kodama S., Takigawa M., Fujimoto T. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am. J. Psychiatry. 156:1999;1205-1208
28. Grachev I.D., Swarnkar A., Szeverenyi N.M., Ramachandran T.S., Apkarian A.V. Aging alters the multichemical networking profile of the human brain: an in vivo (1)H-MRS study of young versus middle-aged subjects. J. Neurochem. 77:2001;292-303
29. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry. 55:1998;145-152
30. Harada M., Miyoshi H., Otsuka H., Nishitani H., Uno M. Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy. Neuroradiology. 43:2001;448-452
31. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry. 156:1999;1336-1341
32. Hollingshead A., Frederick R. Social stratification and psychiatric disorders. Am. Sociol. Rev. 18:1953;163-189
33. Keshavan M.S., Stanley J.A., Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part II. Biol. Psychiatry. 48:2000;369-380
34. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry. 46:1999;729-739
35. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch. Gen. Psychiatry. 55:1998;346-352
36. Lindquist D.M., Hawk R.M., Karson C.N., Komoroski R.A. Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magn. Reson. Med. 43:2000;355-358
37. Lundbom N., Barnett A., Bonavita S., Patronas N., Rajapakse J., Tedeschi G., Di Chiro G. MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magn. Reson. Med. 41:1999;841-845
38. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol. Med. 25:1995;1201-1209
39. McGlashan T.H. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 14:1988;515-542
40. Molina V., Reig S., Sanz J., Benito C., Pascau J., Collazos F., Sarramea F., Artaloytia J.F., Gispert J.D., Luque R., Palomo T., Arango C., Desco M. Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia. Schizophr. Res. 58:2002;305-312
41. Nasrallah H.A., Skinner T.E., Schmalbrock P., Robitaille P.M. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br. J. Psychiatry. 165:1994;481-485
42. Nikkilä H.V., Müller K., Ahokas A., Miettinen K., Rimón R., Andersson L.C. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am. J. Psychiatry. 156:1999;1725-1729
43. Omori M., Murata T., Kimura H., Koshimoto Y., Kado H., Ishimori Y., Ito H., Wada Y. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res. 98:2000;155-162
44. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 361:2003;281-288
45. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry. 56:1999;649-654
46. Saunders D.E., Howe F.A., van den Boogaart A., Griffiths J.R., Brown M.M. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J. Magn. Reson. Imaging. 9:1999;711-716
47. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., Thompson R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 52:1995;399-406
48. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., Thompson R.T. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr. Bull. 22:1996;597-609
49. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13:1993;981-989
50. Vanhamme L., Van den Boogaart A., Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129:1997;35-43
51. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670
52. Yamasue H., Fukui T., Fukuda R., Yamada H., Yamasaki S., Kuroki N., Abe O., Kasai K., Tsujii K., Iwanami A., Aoki S., Ohtomo K., Kato N., Kato T. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport. 13:2002;2133-2137